Johnson & Johnson agrees to pay $5.5bn to settle baby powder lawsuits

TheJournal.ieIndependentCenter7 hr. ago

Johnson & Johnson has offered $5.5 billion to settle approximately 76,000 lawsuits alleging that its talc-based baby powder caused ovarian cancer or mesothelioma. The company denies these claims, stating they lack scientific merit, and has already settled most cases involving asbestos contamination. It ceased selling talc-based baby powder in the U.S. and Canada in 2020. The settlement covers nearly all remaining talc-related claims, though the company still faces a separate lawsuit in the UK over similar allegations. Claimants reportedly seek over £1 billion in compensation.

Bias read (Center): The article presents both the company's stance (denying causation, citing scientific merit) and the plaintiffs' claims (linking product use to cancer). While the issue involves significant legal and health implications, the reporting does not show clear ideological leaning. The framing remains fact-

The Irish TimesIndependent🔒Center8 hr. ago

Johnson & Johnson has agreed to pay up to $5.5 billion to settle tens of thousands of U.S. lawsuits alleging its baby powder and talc products cause ovarian cancer. The settlement covers approximately 76,000 claims, including those in federal and state courts, and marks the end of a decade-long legal battle. The company previously settled cases involving asbestos-related illnesses like mesothelioma. The deal requires approval from 95% of claimants and includes phased payments starting in 2027. Plaintiffs' attorneys described the resolution as favorable after prolonged litigation, while Johnson & Johnson's executives called the claims 'meritless.' The company has historically denied safety concerns and discontinued talc-based baby powder in the U.S. in 2020. Legal battles included court victories for the company, including recent rulings questioning plaintiffs' ability to prove causation.

Bias read (Center): The article presents a balanced account of both sides of the legal dispute, quoting statements from Johnson & Johnson executives who dismiss the claims as 'meritless' and plaintiffs' attorneys who describe the settlement as favorable. It reports factual developments without overtly favoring either阵营

RTÉ NewsState / PublicCenter11 hr. ago

Johnson & Johnson announced a $5.5 billion settlement to resolve approximately 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer. The settlement, which covers 99.75% of remaining talc-related claims, includes both federal and state court cases. The company had previously stopped selling talc-based products in the U.S. in 2020, replacing them with cornstarch alternatives. J&J’s vice president called the claims 'meritless,' stating the company was willing to settle to achieve closure. The settlement follows a recent court ruling that cast doubt on plaintiffs’ ability to prove a direct link between talc and ovarian cancer. The agreement does not cover future lawsuits.

Bias read (Center): While the issue of talc and health risks involves scientific and legal debate, the article presents information from both sides—J&J’s corporate stance and the plaintiffs’ allegations—without overtly favoring either side. The framing remains balanced, focusing on factual developments rather than emot